🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yizhen Guo

The Ohio State University

ORCID: 0009-0002-2994-127X

Biochemistry, Genetics and Molecular BiologyMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy”.

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy

Clinical Lung Cancer(2022)10.1016/j.cllc.2021.12.010

N/A

0DataRank · unranked

44 citations

Lai Wei, Sandip H. Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li +17 more

Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancer

Expert Review of Anticancer Therapy(2022)10.1080/14737140.2022.2094772

N/A

0DataRank · unranked

14 citations

Joy Tang, Yizhen Guo, Christopher C. Coss, Thomas A. Mace, Jason J. Bischof +4 more

Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1683

N/A

0DataRank · unranked

14 citations

Bryan Remaily, Justin Thomas, Kyeongmin Kim, Samuel K. Kulp, Thomas A. Mace +5 more